Myrexis Inc (OTC Pink - No Information:MYRX)

0.178
Data as of Apr 15
 +0.008 / +4.71%
Today’s Change
0.06
Today|||52-Week Range
0.24
+0.62%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$5.9M

Company Description

Myrexis, Inc. is a biopharmaceutical company. It focuses on identifying, evaluating and acquiring commercial-stage biopharmaceutical assets. The company has a pipeline of differentiated product candidates in oncology and autoimmune diseases. Myrexis's oncology programs currently have two active programs: Hsp90 Inhibitor Program and Cancer Metabolism Inhibitor Program. The Hsp90 Inhibitor Program is an MPC-3100, a phase I clinical trial product candidate for cancer treatment. The Cancer Metabolism Inhibitor Program is an MPC-8640, a preclinical compound for the Cancer Metabolism Inhibitor program and is being developed by Myrexis as a drug candidate for the treatment of a variety of cancers. Myrexis was founded in January 2009 and is headquartered in Salt Lake City, UT.

Contact Information

Myrexis, Inc.
305 Chipeta Way
Salt Lake City Utah 84108
P:(801) 214-7800
Investor Relations:

Employees

Shareholders

Mutual fund holders5.15%
Individual stakeholders38.97%
Other institutional15.72%

Top Executives

Jonathan M. CouchmanChairman, President & Chief Executive Officer
Kenton H. ZavitzSenior Director-Clinical Affairs
Andrew BeelenVice President-Clinical Research
Gary S. MatherVice President-Toxicology
Gradon D. KnottsVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.